Milnacipran
CAS 92623-85-3
Overview
Milnacipran is a serotonin–norepinephrine reuptake inhibitor used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatment of major depressive disorder in the US, but it is in other countries
Anant Labs manufacture and furnish high quality Milnacipran impurities for global markets. Our Milnacipran EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS92623-85-3
Mol. FormulaC15H22N2O
Mol. Weight246.354 g/mol
IUPACcis-(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
SMILESCCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2
InChIInChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1
InChI KeyGJJFMKBJSRMPLA-HIFRSBDPSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Milnacipran92623-85-3(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamideMilnacipranumImpulsorF 2207G56VK1HF36DTXSID3048287MILNACIPRAN PIERRE FABRE MEDICAMENTF2207
